Quantcast

Latest Statin Stories

2014-03-24 20:23:34

Five Phase 3 Studies With Evolocumab (AMG 145) to be Featured in Late-Breaking and Clinical Research Presentations - Data Form the Basis of Global Filing Plan THOUSAND OAKS, Calif., March 24, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will present pivotal Phase 3 data from five clinical studies evaluating evolocumab (AMG 145), an investigational fully human monoclonal antibody that inhibits PCSK9, a protein that reduces the liver's ability to remove low-density...

Multiple Sclerosis May Benefit From Statins
2014-03-19 10:09:06

Brett Smith for redOrbit.com - Your Universe Online At first, multiple sclerosis is recognized by sporadic neurological symptoms – a condition called relapsing-remitting MS. Within a decade or so, greater than 50 percent of patients acquire secondary progressive MS, a continuous deterioration of symptoms and boost in disability. Currently, there are no approved drugs for treating this later stage of the disease. However, a newly published study in the UK medical journal The Lancet has...

2014-03-18 23:23:59

The United States Judicial Panel (USJP) on Multidistrict Litigation (MDL) has recently issued a transfer order that will remit 56 Lipitor lawsuits and many more tag-along actions to the District of South Carolina to facilitate this litigation. New York, NY (PRWEB) March 18, 2014 The attorneys at Alonso Krangle applaud the USJP’s recent transfer order that will consolidate many pending Lipitor lawsuits in an MDL that will take place in the District of South Carolina federal court (Case...

2014-03-18 23:02:01

The firm is investigating Lipitor lawsuits on behalf of patients who allegedly developed new-onset Type 2 diabetes due to their use of Lipitor. New York, New York (PRWEB) March 18, 2014 As Lipitor lawsuits (http://www.thelipitorlawsuit.com/) continue to mount in federal court, Bernstein Liebhard LLP notes the publication of a new study that suggests an association between the use of statin drugs like Lipitor and the development of new-onset Type 2 diabetes. The research, which was...

2014-03-17 08:30:17

Study Meets Primary Endpoint of LDL Cholesterol Reduction THOUSAND OAKS, Calif., March 17, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Phase 3 TESLA (Trial Evaluating PCSK9 Antibody in Subjects with LDL Receptor Abnormalities) trial evaluating evolocumab met its primary endpoint of the percent reduction from baseline at week 12 in low-density lipoprotein cholesterol (LDL-C). The percent reduction in LDL-C, or "bad" cholesterol, was clinically meaningful and statistically...

2014-03-14 23:01:01

The Firm is investigating Lipitor Lawsuits on behalf of patients who allegedly developed Type 2 diabetes due to treatment with the cholesterol-lowering statin. New York, New York (PRWEB) March 14, 2014 Lipitor lawsuits (http://www.thelipitorlawsuit.com/ ) continue to mount in the multidistrict litigation now underway in U.S. District Court, District of South Carolina, Bernstein Liebhard LLP reports. According to an updated docket report issued by the U.S. Judicial Panel on Multidistrict...

2014-03-11 00:22:36

When combined with conventional blood clot prevention therapies, statins lowered the occurrence of venous thromboembolic (VTE) events by 48 percent NEW ORLEANS, March 11, 2014 /PRNewswire-USNewswire/ -- Statins have long been known to lower cholesterol and, more recently, to decrease the risk of deep vein thrombosis (blood clots) in healthy, non-surgical patients. New, first-of-its-kind research presented today at the 2014 Annual Meeting of the American Academy of Orthopaedic...

2014-03-08 23:01:36

The Firm is evaluating Lipitor lawsuits on behalf of plaintiffs who allegedly developed new-onset Type 2 diabetes due to their use of Lipitor. New York, NY (PRWEB) March 08, 2014 Lipitor lawsuits (http://www.thelipitorlawsuit.com/) that claim the statin drug caused patients to develop new-onset Type 2 diabetes continue to mount in courts around the country, Bernstein Liebhard LLP reports. According to court documents, four women recently filed claims in U.S. District Court, Northern...

2014-03-06 08:30:13

- A significant addition that complements the company's innovative suite of diagnostics and services, Boston Heart's MPO is easy for clinicians to use and FDA-cleared. FRAMINGHAM, Mass., March 6, 2014 /PRNewswire/ -- Boston Heart Diagnostics Corporation, a pioneer in integrating next-generation diagnostics into personalized nutrition and lifestyle programs for patients with or at risk for heart disease, announced the commercial launch of an FDA-cleared MPO (myeloperoxidase) test, a...

That Angry Outburst May Lead To Heart Attack or Stroke
2014-03-04 10:02:56

Lawrence LeBlond for redOrbit.com - Your Universe Online It is known that bouts of anger can raise a person’s stress level and continued stress can lead to other health-related issues such as heart attack and stroke. But a new look at several studies has led researchers to the determination that anger itself can cause stroke or heart attack within a few hours of an outburst. Dr Murray Mittleman, of Harvard School of Public Health, and colleagues found that people who lose their temper...


Word of the Day
virgule
  • A punctuation mark (/) used to separate related items of information.
  • A little rod; a twig.
This word comes from the Late Latin 'virgula,' accentual mark, a diminutive of 'virga,' rod.
Related